Followers | 144 |
Posts | 10941 |
Boards Moderated | 0 |
Alias Born | 04/02/2006 |
![](https://investorshub.advfn.com/uicon/69574.png?cb=1512657362)
Tuesday, March 21, 2017 1:55:12 PM
Based on recent guidance, CVR Management has expectations of FDA approval by Q2 2018, therefore would be going commercial shortly thereafter. Time lines are difficult to predict based on all the moving parts : Tertiary trial results, then Pivotal Trials then FDA submission. Management is currently beginning tertiary trials at Jefferson.
Thankyou for the support
Scott Koyich
Investor Relations
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM